Paper761001
Metabolic consequences of atenolol and propranolol in treatment of essential hypertension.
Day JL and 3 others. Br Med J, 1979. Cited by 220 papers, by iCite.
Cite this record
ConductScience Library. Metabolic consequences of atenolol and propranolol in treatment of essential hypertension. Papers, record 761001. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/761001
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Metabolic consequences of atenolol and propranolol in treatment of essential hypertension.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Atenolol | Major topic |
| Hypertension | Major topic |
| Propanolamines | Major topic |
| Propranolol | Major topic |
| Adult | |
| Blood Glucose | |
| Cholesterol | |
| Fatty Acids, Nonesterified | |
| Glucagon | |
| Growth Hormone | |
| Humans | |
| Insulin | |
| Male | |
| Middle Aged | |
| Triglycerides |
Source PubMed
References10
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 984073 | Elevation of serum lipid levels during diuretic therapy of hypertension. | Am J Med | 1976 | https://conductscience.org/library/papers/984073 | PubMed |
| 2 | 17448 | Beta-blockers and lipid metabolism. | Br Med J | 1977 | https://conductscience.org/library/papers/17448 | PubMed |
| 3 | 184363 | Effect of chronic administration of propranolol on lipoprotein composition. | Metabolism | 1976 | https://conductscience.org/library/papers/184363 | PubMed |
| 4 | 4696745 | Propranolol and hypertriglyceridemia. | Atherosclerosis | 1973 | https://conductscience.org/library/papers/4696745 | PubMed |
| 5 | 4125216 | [Effect of beta sympatholytic agent ICI 50172 (Dalzic) in various cardiovascular diseases]. | Med Klin | 1973 | https://conductscience.org/library/papers/4125216 | PubMed |
| 6 | 4399102 | The effect of beta-adrenergic blocking agents on serum lipids. | Atherosclerosis | 1971 | https://conductscience.org/library/papers/4399102 | PubMed |
| 7 | 4379758 | On sympathetic regulation of carbohydrate metabolism in the liver. | J Pharm Pharmacol | 1965 | https://conductscience.org/library/papers/4379758 | PubMed |
| 8 | 46384 | Effects of long-term practolol therapy on plasma-lipids after acute myocardial infarction. | Lancet | 1975 | https://conductscience.org/library/papers/46384 | PubMed |
| 9 | 238094 | The metabolic consequences of adrenergic blockade: a reveiw. | Metabolism | 1975 | https://conductscience.org/library/papers/238094 | PubMed |
| 10 | 5429278 | The effect of physical training on insulin production in obesity. | Metabolism | 1970 | https://conductscience.org/library/papers/5429278 | PubMed |
Cited by40
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 220 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 23536766 | Pharmacometabolomics reveals racial differences in response to atenolol treatment. | PLoS One | 2013 | https://conductscience.org/library/papers/23536766 | PubMed |
| 20795842 | Atenolol exposure and risk for development of adverse metabolic effects: a pilot study. | Pharmacotherapy | 2010 | https://conductscience.org/library/papers/20795842 | PubMed |
| 7433322 | Beta-adrenoceptor-blocking drugs, growth hormone and acromegaly. | Postgrad Med J | 1980 | https://conductscience.org/library/papers/7433322 | PubMed |
| 7286043 | Serum lipoprotein changes during atenolol treatment of essential hypertension. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7286043 | PubMed |
| 7104159 | Effect of pindolol on serum lipids and lipid metabolizing enzymes. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7104159 | PubMed |
| 7104158 | Antihypertensive drugs and blood lipids: the Oslo study. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7104158 | PubMed |
| 7093112 | The short term effects of propranolol, atenolol and labetalol on antipyrine kinetics in normal subjects. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7093112 | PubMed |
| 7037030 | Oxprenolol, methyldopa and lipids in diabetes mellitus. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7037030 | PubMed |
| 6992822 | Atenolol v placebo in mild hypertension: renal metabolic and stress antipressor effects. | Br J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/6992822 | PubMed |
| 6734694 | Effect of oxprenolol and metoprolol on serum lipid concentration. | Eur J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6734694 | PubMed |
| 6712860 | Changes in blood chemistry in hypertensive patients during propranolol therapy. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6712860 | PubMed |
| 6661351 | Increased platelet adhesion and aggregation in hypertensive patients: effect of atenolol. | Br J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6661351 | PubMed |
| 6145480 | Beta adrenoceptor blockade and responses of serum lipids to a meal and to exercise. | Br Med J (Clin Res Ed) | 1984 | https://conductscience.org/library/papers/6145480 | PubMed |
| 6144502 | Effects of antihypertensive drugs on endocrine function. | Drugs | 1984 | https://conductscience.org/library/papers/6144502 | PubMed |
| 6143851 | [Antihypertensive therapy and lipid metabolism]. | Klin Wochenschr | 1984 | https://conductscience.org/library/papers/6143851 | PubMed |
| 6143667 | Effect of beta-blocking drugs on beta-cell function and insulin sensitivity in hypertensive non-diabetic patients. | Eur J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6143667 | PubMed |
| 6141317 | [Blood pressure during isometric and dynamic exercise under long-term antihypertensive treatment with beta receptor blockaders and diuretics]. | Klin Wochenschr | 1983 | https://conductscience.org/library/papers/6141317 | PubMed |
| 6137813 | Thiazides, beta blockers and lipoproteins. | Postgrad Med J | 1983 | https://conductscience.org/library/papers/6137813 | PubMed |
| 6132652 | Which beta blocker? | Br Med J (Clin Res Ed) | 1983 | https://conductscience.org/library/papers/6132652 | PubMed |
| 6127218 | Effects of a new long-acting beta-blocker bopindolol (LT 31-200) on blood pressure, plasma catecholamines, renin and cholesterol in patients with arterial hypertension. | Eur J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6127218 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GCG | 2641 | PubTator's text mining | https://conductscience.org/library/genes/2641 | NCBI Gene |
| GH1 | 2688 | PubTator's text mining | https://conductscience.org/library/genes/2688 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/761001
GET https://conductscience.org/api/papers/v1/761001/cited_by?page=2